Spencer Pharmaceutical Inc. (SPPH)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 7, 2026
Spencer Pharmaceutical Market Cap
Spencer Pharmaceutical has a market cap or net worth of $271 as of October 9, 2026. It is the 52,649th most valuable company in the world and the 8,674th biggest in the United States.
Market Cap
271.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,674 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since April 8, 2010, Spencer Pharmaceutical's market cap has decreased from 32.47M to 271.00, a decrease of -100.00%. That is a compound annual growth rate of -50.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 271.00 | - |
| Dec 23, 2025 | 271.00 | - |
| Dec 7, 2023 | 271.00 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biora Therapeutics | 442.00 |
| Tengion | 402.00 |
| PharmaRoth Labs | 391.00 |
| Nabriva Therapeutics | 323.00 |
| Predictive Technology Group | 317.00 |
| Sirona Biochem | 266.00 |
| Nanobac Pharmaceuticals | 250.00 |
| Virpax Pharmaceuticals | 249.00 |